FaB

Fractures and Bisphosphonates: A double-blind, randomised controlled trial on the effect of alendronic acid on healing and clinical outcomes of wrist fractures.

This study aims to find out if alendronic acid, a drug widely used in post-menopausal women with osteoporosis to prevent bone fractures, has any effect on the healing of wrist fractures.
 
FaB logo

Chief Investigator: Professor Stuart Ralston

Number and location of participating sites (by region/ country): 16 UK sites
EudraCT number: 2011-000988-28
 
Funder: Arthritis Research UK
Start and End date:
of grant award:  Feb 2011- 31 Nov 2016
 
Current Status: Now published - https://doi.org/10.1002/jbmr.3679               

View the protocol document. 

 
Trial Unblinding Information: Please refer to the study protocol.
 
UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.
ECTU FaB GDPR privacy statement (767.94 KB / 0_11JUL2018)
 
Contact details: Sponsor(s) University of Edinburgh / NHS Lothian 
 
 
ECTU Involvement: Trial Management, statistics and data management, research nurses.
(UKCRC)

This article was published on